Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines.
Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines.
复制标题
DOI:
10.1126/science.abq0203
复制
发表时间:
2022-08-19
期刊:
影响因子:
--
通讯作者:
中科院分区:
文献类型:
--
作者:
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant of concern comprises several sublineages, with BA.2 and BA.2.12.1 having replaced the previously dominant BA.1 and with BA.4 and BA.5 increasing in prevalence worldwide. We show that the large number of Omicron sublineage spike mutations leads to enhanced angiotensin-converting enzyme 2 (ACE2) binding, reduced fusogenicity, and severe dampening of plasma neutralizing activity elicited by infection or seven clinical vaccines relative to the ancestral virus. Administration of a homologous or heterologous booster based on the Wuhan-Hu-1 spike sequence markedly increased neutralizing antibody titers and breadth against BA.1, BA.2, BA.2.12.1, BA.4, and BA.5 across all vaccines evaluated. Our data suggest that although Omicron sublineages evade polyclonal neutralizing antibody responses elicited by primary vaccine series, vaccine boosters may provide sufficient protection against Omicron-induced severe disease. The Omicron strain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first detected in 2021 and is now dominant across the globe. Bowen et al. show that the Omicron sublineages BA.1, BA.2, BA.2.12, and BA.4/5 have increased affinity for the ACE2 receptor on human cells, but show decreased cell-cell fusion. They used pseudovirus to measure neutralizing activity against Omicron sublineages in plasma from individuals who were previously infected or vaccinated with one of seven vaccines, all based on the Wuhan-Hu-1 variant. For both vaccinees and convalescents, there was severe dampening of neutralizing activity. Boosting with either the same vaccine used initially or one of the other Wuhan-Hu-1–based vaccines increased neutralization across all vaccines evaluated. —VV The increasingly prevalent Omicron BA.4/BA.5 sublineages exhibit enhanced receptor binding and escape from neutralizing antibodies.
登录
查看更多内容
DOI:
10.1056/nejmoa2119451
发表时间:
2022-04-21
期刊:
The New England journal of medicine
影响因子:
--
作者:
Andrews N;Stowe J;Kirsebom F;Toffa S;Rickeard T;Gallagher E;Gower C;Kall M;Groves N;O'Connell AM;Simons D;Blomquist PB;Zaidi A;Nash S;Iwani Binti Abdul Aziz N;Thelwall S;Dabrera G;Myers R;Amirthalingam G;Gharbia S;Barrett JC;Elson R;Ladhani SN;Ferguson N;Zambon M;Campbell CNJ;Brown K;Hopkins S;Chand M;Ramsay M;Lopez Bernal J
通讯作者:
Lopez Bernal J
DOI:
10.1016/j.xcrm.2021.100230
发表时间:
2021-04-20
期刊:
Cell reports. Medicine
影响因子:
--
作者:
Hassan AO;Feldmann F;Zhao H;Curiel DT;Okumura A;Tang-Huau TL;Case JB;Meade-White K;Callison J;Chen RE;Lovaglio J;Hanley PW;Scott DP;Fremont DH;Feldmann H;Diamond MS
通讯作者:
Diamond MS
影响因子:
56.9
作者:
Cai, Yongfei;Zhang, Jun;Chen, Bing
通讯作者:
Chen, Bing
DOI:
10.1101/2021.08.09.21261290
发表时间:
2022-01-07
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Gilbert, Peter B;Montefiori, David C;Koup, Richard A
通讯作者:
Koup, Richard A
影响因子:
17.1
作者:
Collier AY;Brown CM;McMahan KA;Yu J;Liu J;Jacob-Dolan C;Chandrashekar A;Tierney D;Ansel JL;Rowe M;Sellers D;Ahmad K;Aguayo R;Anioke T;Gardner S;Siamatu M;Bermudez-Rivera L;Hacker MR;Madoff LC;Barouch DH
通讯作者:
Barouch DH